Posts Tagged ‘drug

August 16, 2021
Our Take: Honor Technologies acquires Home Instead with goal of scaling up high-quality senior home care
Read More
August 09, 2021
Our Take: COVID-19 appears to be an independent risk factor for heart attack, stroke, large study shows
Read More
August 02, 2021
Our Take: As FDA approves first interchangeable insulin biosimilar, insurers take steps to restrict use of biosimilars
Read More
July 26, 2021
Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm
Read More
July 19, 2021
Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications
Read More
July 12, 2021
Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week
Read More
June 28, 2021
Our Take: Blues plans fund new startup to address high drug prices
Read More
June 21, 2021
Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system
Read More
June 14, 2021
Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy
Read More
June 07, 2021
Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools
Read More
May 24, 2021
Our Take: JPMorgan Chase picks up where Haven left off
Read More
May 17, 2021
Our Take: BD to spin off diabetes business into new publicly traded company
Read More
May 10, 2021
Our Take: Walmart to acquire on-demand telehealth provider MeMD
Read More
May 03, 2021
Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘drug

Our Take: Honor Technologies acquires Home Instead with goal of scaling up high-quality senior home care

Our Take: COVID-19 appears to be an independent risk factor for heart attack, stroke, large study shows

Our Take: As FDA approves first interchangeable insulin biosimilar, insurers take steps to restrict use of biosimilars

Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm

Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications

Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week

Our Take: Blues plans fund new startup to address high drug prices

Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system

Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy

Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools

Our Take: JPMorgan Chase picks up where Haven left off

Our Take: BD to spin off diabetes business into new publicly traded company

Our Take: Walmart to acquire on-demand telehealth provider MeMD

Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘drug

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives